Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Jean Michon"'
Publikováno v:
Pediatric Blood & Cancer
Autor:
Isabelle Pellier, Jean Michon, Hélène Sudour-Bonnange, Hervé Brisse, Sabine Irtan, Arnauld Verschuur, Virginie Languillat-Fouquet, Sabine Sarnacki, Anne Notz-Carrere, Magali Morelle, Christophe Bergeron, Cécile Boulanger, Frédérique Dijoud, Claire Freycon, Estelle Thebaud, Marie-Dominique Tabone, Aurore Coulomb-L'Hermine, Antoine Liné, Georges Audry, Claudia Pasqualini
Publikováno v:
Pediatric Blood and Cancer
Pediatric Blood and Cancer, 2020, 67 (6), ⟨10.1002/pbc.28201⟩
Pediatric blood & cancer, 67(6):e28201. Wiley-Liss Inc.
Pediatric Blood and Cancer, Wiley, 2020, 67 (6), ⟨10.1002/pbc.28201⟩
Pediatric Blood and Cancer, 2020, 67 (6), ⟨10.1002/pbc.28201⟩
Pediatric blood & cancer, 67(6):e28201. Wiley-Liss Inc.
Pediatric Blood and Cancer, Wiley, 2020, 67 (6), ⟨10.1002/pbc.28201⟩
Background Liver metastases are rare in children with Wilms tumor (WT), and their impact on the outcome is unclear. Patients and methods The French cohort of patients with WT presenting liver metastases at diagnosis and enrolled in the International
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32805bf3eea0cb3bcc851c0f04fdc340
https://shs.hal.science/halshs-03036047
https://shs.hal.science/halshs-03036047
Autor:
Pascal Chastagner, Olivier Cougnenc, Aurore Oudoux, Gudrun Schleiermacher, Dominique Valteau-Couanet, Stéphanie Proust, Isabelle Ferry, Hélène Kolesnikov-Gauthier, Jean Michon, Anne-Sophie Defachelles, Emilie Bogart
Publikováno v:
Journal of Pediatric Hematology/Oncology. 40:426-432
High-risk neuroblastoma is characterized by poor long-term survival, especially for very high-risk (VHR) patients (poor response of metastases after induction therapy). The benefits of a tandem high-dose therapy and hematologic stem cell reinfusion (
Autor:
Nathalie Clement, Jean Michon, Gudrun Schleiermacher, Paul Fréneaux, Gaëlle Pierron, Hervé Brisse, Bernard Escudier, Irene Jiménez, Daniel Orbach, Sabine Sarnacki, François Doz
Publikováno v:
Journal of Pediatric Hematology/Oncology. 39:e279-e284
Antiangiogenic drugs are currently standard of care in adults with renal cell carcinoma (RCC), including translocation RCC. Although antitumor activity and toxicity profile are well known in adults, few data have been reported in children. Here we pr
Autor:
Michel Zerah, Louise Galmiche-Rolland, Hervé Brisse, Luc Joyeux, Sabine Irtan, Christophe Glorion, Jean Michon, Caroline Harte, Sabine Sarnacki, Timothé de Saint Denis, Luca Pio, T. Odent, Dominique Valteau-Couanet, Thomas Blanc
Publikováno v:
Pediatric Blood & Cancer. 66
INTRODUCTION: Prognosis of dumbbell neuroblastoma (NBL) is mainly determined by the sequelae induced by the tumor itself and the neurosurgical approach. However, after primary chemotherapy, surgical management of the residual tumor, especially the sp
Autor:
Virginie Gandemer, Jean Michon, Anne Jourdain, Catherine Patte, Geneviève Plat, Nathalie Aladjidi, Charlotte Rigaud, Thierry Leblanc, Veronique Minard-Colin, Anne Lambliotte, Judith Landman-Parker, Marie-Laure Couec, Anne Auperin, Stéphanie Haouy
Publikováno v:
Pediatric bloodcancer. 66(9)
Introduction In order to describe relapsed B-cell non-Hodgkin lymphoma and mature acute leukemia in children/adolescents treated with the Lymphomes Malins B (LMB) regimen and their outcome in the rituximab era, relapses in the French LMB2001 study we
Autor:
Jean Michon, B. Lescoeur, Anne Auvrignon, B. Pellegrino, M. Guillon, A. Petit, M. Gioia, N. Nisenbaum, Daniel Orbach, Nathalie Gaspar
Publikováno v:
Revue d'Oncologie Hématologie Pédiatrique. 4:106-112
Resume Propos L’objectif est de decrire les modalites et les besoins de soins palliatifs durant les 3 derniers mois de vie des enfants decedes d’un cancer ou d’une pathologie hematologique en 2010 en Ile-de-France. Methodes Il s’agit d’une
Autor:
Jean Michon, Carole Coze, Pascal Chastagner, Dominique Valteau-Couanet, D. Avenell, Judith Landman-Parker, Hervé Rubie, A.-M. Rivière, Gilles Vassal, Christophe Bergeron, Guy Leverger, Yves Bertrand, Dominique Couanet, François Doz, Y. Perel, André Baruchel
Publikováno v:
Archives de Pédiatrie. 22:1217-1222
Resume Introduction Les enfants et adolescents atteints de cancer sont pris en charge en France par des equipes pluri-professionnelles au sein de centres specialises d’onco-hematologie pediatrique, labellises par l’Institut national du cancer, qu
Autor:
P Chastagner, Gilles Vassal, Arnauld Verschuur, Isabelle Aerts, N. André, Birgit Geoerger, Francois P. Doz, Stéphane Ducassou, Nadège Corradini, Jean Michon, D. Frappaz, J. Landman-Parker, N. Entz-Werlé, A. Baruchel, P. Leblond, M. Gambart
Publikováno v:
Revue d'Oncologie Hématologie Pédiatrique. 3:62-69
Resume Le cancer reste la premiere cause de deces par maladie chez l’enfant et l’adolescent. Donner un large acces aux innovations therapeutiques est un objectif strategique majeur de l’onco-hematologie pediatrique en Europe. Objectif Analyser
Autor:
Sabine Irtan, Chloé Le Cossec, Sabine Sarnacki, Jean Michon, Gudrun Schleiermacher, Louise Galmiche-Rolland, Hervé Brisse, Sandra Canale, Caroline Elie, Dominique Valteau-Couanet, Veronique Minard-Colin
Publikováno v:
Pediatric Blood & Cancer. 62:1543-1549
Background Patients with neuroblastoma are now stratified at diagnosis according to the presence and number of image-defined risk factors (IDRFs). We examined the added value of IDRF assessment after neoadjuvant chemotherapy for predicting surgical r